2007
DOI: 10.1016/j.mri.2007.04.016
|View full text |Cite
|
Sign up to set email alerts
|

Detection of toxoplasmic lesions in mouse brain by USPIO-enhanced magnetic resonance imaging

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
12
0

Year Published

2009
2009
2015
2015

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 17 publications
(12 citation statements)
references
References 24 publications
0
12
0
Order By: Relevance
“…5, which reflect blood-brain barrier impairment and/or inflammatory reactions associated with these lesions. 75 …”
Section: Res-directed Mrimentioning
confidence: 99%
“…5, which reflect blood-brain barrier impairment and/or inflammatory reactions associated with these lesions. 75 …”
Section: Res-directed Mrimentioning
confidence: 99%
“…A study of 30 mice acutely infected with T. gondii (by intracerebral injection of tachyzoites) were imaged with Gad and/or USPIO at various time-periods in the acute (1 week) infectious process, followed by microscopic examination. 66 The USPIO imaging (postcontrast T 2 and T 2 * weighted images, decreased signal) identified several T. Gondii lesions not visualized on either unenhanced T 2 and T 2 *, or Gad-enhanced T 1 -weighted MRI. However, the Gad imaging identified breaks in the blood-brain barrier more effectively than did the USPIO.…”
mentioning
confidence: 95%
“…It may not be positive in "preclinical" or early-stage infections. 65,66 Ultra-small superparamagnetic particles of iron oxide (USPIO), a new contrast agent for MRI, has been used recently to study neuroinflammatory diseases. Circulating monocytes in the bloodstream internalize these particles, which travel within the inflammatory cells into areas of phagocytosis.…”
mentioning
confidence: 99%
“…The relaxation effects of iron oxide nanoparticles depend on their local concentration, compartmentalisation (inside or outside the cells), distribution in their microenvironment (interactions with surrounding protons) and on the applied field strength. Most experimental works are performed at high field (>3 T) [6,14,15], in order to improve spatial resolution in small animals. With the recent development of 7 T head and whole-body scanners [16,17] clinical USPIO-enhanced MRI studies may also be performed at high field in the future, as some USPIOs, such as ferumoxtran-10, are already approved for use in humans [18,19].…”
Section: Introductionmentioning
confidence: 99%